by Jennifer Rainey Marquez-Georgia State | Aug 22, 2019 | BioPharma, News
Credit: Secretaria Municipal de Saúde de Porto Alegre/Flickr A unique formulation of multiple amino acids inhibits the replication of Zika virus by up to 90% in human and non-human primate cells, according to a new study. The researchers tested a novel formulation of...
by Gitte Pedersen, M.Sc.h. CEO | Oct 4, 2018 | BioPharma, Genomics, Oncology
Congratulations! Genomic Expression won EIC and got featured in Forbes We were selected as one of 50 European companies to present at EIC Innovators Summit arranged by the EEC specifically for beneficiaries of Horizon2020 SME grants. You can download the booklet...
by John Miller | Sep 28, 2018 | BioPharma, Oncology, Pharmaceutical
ZURICH (Reuters) – Swiss drugmaker Roche upped its bet on personalized cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mutations from solid tumors from a patient’s blood. The blood test,...
by John Miller | Apr 22, 2018 | BioPharma
ZURICH (Reuters) – Swiss drugmaker Roche on Friday won a key European panel’s recommendation for its multiple sclerosis drug Ocrevus, which is on track for nearly $1 billion in sales in 2017 after winning U.S. regulators’ go-ahead earlier this year. FILE PHOTO:...
by Tamara Mathias | Apr 22, 2018 | BioPharma
A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder (Reuters) – Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the...
by Reuters Staff | Apr 21, 2018 | BioPharma
FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski FRANKFURT (Reuters) – Merck KGaA will seek development partners for experimental treatments including tepotinib as the German...
